DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 804 filers reported holding DANAHER CORPORATION in Q3 2013. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $477,000 | -41.6% | 6,079 | -24.8% | 0.10% | -29.9% |
| Q2 2016 | $817,000 | +134.1% | 8,087 | +97.0% | 0.15% | +59.8% |
| Q1 2016 | $349,000 | -52.4% | 4,105 | -48.0% | 0.09% | -38.7% |
| Q4 2015 | $733,000 | +28.8% | 7,888 | +18.0% | 0.15% | +15.4% |
| Q3 2015 | $569,000 | +14.3% | 6,683 | +14.9% | 0.13% | +12.1% |
| Q2 2015 | $498,000 | +42.7% | 5,818 | +41.7% | 0.12% | +26.1% |
| Q1 2015 | $349,000 | +42.4% | 4,105 | +43.5% | 0.09% | +22.7% |
| Q4 2014 | $245,000 | -94.7% | 2,861 | -95.3% | 0.08% | -92.5% |
| Q3 2014 | $4,646,000 | -3.8% | 61,143 | -0.3% | 1.00% | -5.1% |
| Q2 2014 | $4,830,000 | +39.7% | 61,343 | +33.1% | 1.05% | +53.1% |
| Q1 2014 | $3,458,000 | -3.2% | 46,104 | -0.3% | 0.69% | -1.9% |
| Q4 2013 | $3,572,000 | +11.3% | 46,264 | -0.1% | 0.70% | +47.4% |
| Q3 2013 | $3,210,000 | +10.1% | 46,314 | +0.6% | 0.48% | +12.3% |
| Q2 2013 | $2,915,000 | – | 46,044 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |